This digital document is an article from Skin & Allergy News, published by International Medical News Group on July 1, 2001. The length of the article is 708 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: FDA Approval of Botox for Glabellar Lines Expected.Author: Sharon WorcesterPublication: Skin & Allergy News (Magazine/Journal)Date: July 1, 2001Publisher: International Medical News GroupVolume: 32 Issue: 7 Page: 1Distributed by Thomson Gale

…
Click Here For Big Discounts On FDA Approval of Botox for Glabellar Lines Expected.: An article from: Skin & Allergy News at Amazon

Post from: Botox Products And Treatments

FDA Approval of Botox for Glabellar Lines Expected.: An article from: Skin & Allergy News

Formulated for use on both the face and the eye contour area, Nuxe Serum Merveillance Expression Lines Serum delivers an immediate soft focus effect and offers clinically proven botanical effectiveness in helping reduce all parameters of visible expression lines: number, surface and length. An exceptional combination of 3 botanical active ingredients: Mimosa Seeds, Calendula Officinalis Petals and Althea Root. Containing a high concentration of Oak Extract, this serum works to de-t (more…)

Post from: Botox Products And Treatments

Nuxe Paris Serum Merveillance – Expression Lines Serum